COVID-19: пациент с сердечно-сосудистой патологией в зоне особого риска
https://doi.org/10.26442/2075082X.2020.2.200231
Аннотация
Об авторах
И. Е. ЧазоваРоссия
Ю. В. Жернакова
Россия
О. Д. Остроумова
Россия
Список литературы
1. Российской медицинское общество по артериальной гипертонии. Рекомендации по ведению больных артериальной гипертонией с метаболическими нарушениями и сахарным диабетом 2-го типа. Системные гипертензии. 2020; 17 (1): 7-45
2. Bauters C, Lemesle G, Meurice T et al. Prognostic impact of b-blocker use in patients with stable coronary artery disease. Heart 2014; 100: 1757-61
3. Чазова И.Е., Жернакова Ю.В. от имени экспертов. Клинические рекомендации. Диагностика и лечение артериальной гипертонии. Системные гипертензии. 2019; 16 (1)
4. Williams B, Mancia G, Spiering W et al. 2018 ESC/ESH Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens 2018; 36 (10): 1953-2041. DOI: 10.1097/HJH.0000000000001940
5. Struijker-Boudier H et al. The Need for Combination Antihypertensive Therapy to Reach Target Blood Pressures: What Has Been Learned From Clinical Practice and Morbidity-Mortality Trials? Int J Clin Pract 2007; 61: 1592-602
6. Cruckshank JM. Are We Misunderstanding Beta-Blockers. Int J Cardiol 2007; 120: 10-27
7. Palatini P et al. Impact of Increased Heart Rate on Clinical Outcomes in Hypertension: Implications for Antihypertensive Drug Therapy. Drugs 2006; 66: 133-44
8. Murdoch D, Heel RC. Amlodipine. A Review of Its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Use in Cardiovascular Disease. Drugs 1991; 41 (3): 478-505. DOI: 10.2165/00003495-199141030-00009
9. Rana R, Patil A. Efficacy and safety of bisoprolol plus amlodipine fixed dose combination in essential hypertension. Indian Pract 2008; 61: 225-34
10. Parinello G, Paterna S, Torres D et al. One year Renal and Cardiac Effects of Bisoprolol versus Losartan in Recently Diagnosed Hypertensive Patients. Clin Drug Investigation 2009; 29: 591-600
11. Klein LW, Richard AD, Holt J et al Effects of chronic tobacco smoking on the coronary circulation. J Am Coll Cardiol 1983; 1 (2 Pt 2); 421-6
12. Cruickshank JM. The Modern Role of Beta-blockers in Cardiovascular Medicine. Shelton: CT Peoples Medical Publishing House-USA, 2011; Fig 3-32a
13. Buhler FR, Berglund G, Anderson OK et al. Double-blind comparison of cardioselective B-blockers bisoprolol and atenolol in in hypertension: the Bisoprolol International Multicenter Study (BIMS). J Cardiovasc Pharmacol 1986; 8 (Suppl. 11): S 122-7
Рецензия
Для цитирования:
Чазова И.Е., Жернакова Ю.В., Остроумова О.Д. COVID-19: пациент с сердечно-сосудистой патологией в зоне особого риска. Системные гипертензии. 2020;17(2):76-83. https://doi.org/10.26442/2075082X.2020.2.200231
For citation:
Chazova I.E., Zhernakova Y.V., Ostroumova O.D. COVID-19: a patient with cardiovascular disease at high risk. Systemic Hypertension. 2020;17(2):76-83. (In Russ.) https://doi.org/10.26442/2075082X.2020.2.200231